Back
Cidara Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
CDTX
Cidara Therapeutics, Inc.
Last Price:
$221.38
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
Cidara Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cidara Therapeutics, Inc. has on average historically risen by 79.3% based on the past 10 years of stock performance.
-
Cidara Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Cidara Therapeutics, Inc. Stock Undervalued?The current Cidara Therapeutics, Inc. [CDTX] share price is $221.38. The Score for CDTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Cidara Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cidara Therapeutics, Inc. has on average historically risen by 79.3% based on the past 10 years of stock performance.
Cidara Therapeutics, Inc. Stock Rating
Buy
64
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. overpriced?
-
Cidara Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Cidara Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cidara.com
52-Week Data
52-Week High:
221.42
52-Week Low:
15.22
Prediction Charts
Market Cap:
7B
Price in USD:
221.38
Volume:
0
Beta:
1.55
Technical Analysis
SMA50:
221.17
SMA100:
184.38
SMA200:
117.90
52-Wk Change:
933.52%
Stock Predictions
-
Is Cidara Therapeutics, Inc. stock public?Yes, Cidara Therapeutics, Inc. is a publicly traded company.
-
What is the Cidara Therapeutics, Inc. stock quote today?The Cidara Therapeutics, Inc. stock price is 221.38 USD today.
-
How to buy Cidara Therapeutics, Inc. stock online?You can buy Cidara Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-5 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-6 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-9 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-10 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-11 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-12 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-13 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-17 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-18 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-19 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-20 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-23 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-24 | 221.38 | 221.38 | 221.38 | 221.38 |
| Feb-25 | 221.38 | 221.38 | 221.38 | 221.38 |
Cidara Therapeutics, Inc. Earnings
Cidara Therapeutics, Inc. Earnings Report: Per Share Cidara Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cidara Therapeutics, Inc. Forecast Revenue Growth
Cidara Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cidara Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.59 per share.
* Cidara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.